LGND
LIGAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$297.28
+0.59%Leverage
- Debt / equity
- 1.17x
- Net debt / equity
- 0.13x
- Debt / assets
- 0.52x
- Debt / EBITDA
- 4.13x
- Net debt / EBITDA
- 0.46x
Liquidity & coverage
- Current ratio
- 31.18x
- Quick ratio
- 30.96x
- Cash ratio
- 29.05x
- Interest coverage
- 16.31x
- EBITDA / interest
- 44.27x
- Working capital
- $1.4B
Cash & dividend
- FCF / debt
- 0.12x
- Cash flow / debt
- 0.12x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -95.1%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026